Humacyte receives Nasdaq notice of non-compliance with minimum bid price rule

Humacyte, Inc.

• Common stock bid price closed below $1.00 for 30 consecutive business days ended July 30, 2026.
• Company has 180 calendar days, until January 27, 2027, to regain compliance.
• To regain compliance, closing bid price must be $1.00 or more for at least 10 consecutive business days.
• No immediate effect on listing; stock continues trading under HUMA on Nasdaq Global Select Market.
• Company intends to monitor and consider options but cannot assure compliance.